Ovarian Cancer

Ovarian Cancer
2024-12-17T03:05:21.091Z

REJOICE-Ovarian01

REJOICE-Ovarian01
Ovarian cancer

A Phase 2/3, Multicenter, Randomized Study of Raludotatug Deruxtecan (R-DXd), a CDH6-directed Antibody-drug Conjugate, in Subjects with Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancers

A Phase 2/3, Multicenter, Randomized Study of Raludotatug Deruxtecan (R-DXd), a CDH6-directed Antibody-drug Conjugate, in Subjects with Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancers

Trial overview

Clinical Area

Medical oncology

Disease / Condition

Ovarian cancer

Study Phase

ll/lll

Trial Identifiers
GenesisCare Location(s)
North Shore
location pin icon

North Shore Health Hub, Tower A, Level 1, 7 Westbourne St, St Leonards, NSW, 2065, Australia

phone icon (02) 8037 4100 email icon admin.northshore@genesiscare.com
NSW
North Shore
St Andrew's Precinct (Oncology)
location pin icon

Level 1, 337 South Terrace, Adelaide, SA, 5000, Australia

phone icon (08) 8228 6700 email icon infooncologysa@genesiscare.com
SA
St Andrew's Precinct (Oncology)
Principal Investigator(s)
Medical Oncologist

Dr Sally Baron-Hay

FRACP MBBS

Dr Sally Baron-Hay
location pin icon

North Shore

View Profile
Profile Image - Dr Sally Baron-Hay
Medical Oncologist

Dr Ayesha Salim

MBBS FRACP

Dr Ayesha Salim
location pin icon

Elizabeth Vale at Calvary Central Districts Hospital (Oncology) +1

View Profile
Profile Image - Dr  Ayesha Salim

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.